Top Markets
Coin of the day
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc.

BSPM
Κατάταξη σε μετοχές #42724
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets... Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Τιμή μετοχής
$0.0001
Τελευταίος συγχρονισμός: 2026-08-11
Κεφαλαιοποίηση
$264.00
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
CN
Εμπόριο Biostar Pharmaceuticals, Inc. (BSPM)

Κατηγορία

Η τιμή BSPM με την κεφαλαιοποίηση του Β
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
BSPM
$0.0001
Κεφαλαιοποίηση αγοράς του Biostar Pharmaceuticals, Inc.(BSPM)
Κεφαλαιοποίηση: $264.00
Μέχρι το August 2026, η Biostar Pharmaceuticals, Inc. έχει χρηματιστηριακή αξία $264.00. Αυτό καθιστά τη Biostar Pharmaceuticals, Inc. την 42724th πιο πολύτιμη εταιρεία στον κόσμο βάσει της κεφαλαιοποίησης σύμφωνα με τα δεδομένα μας. Η χρηματιστηριακή κεφαλαιοποίηση είναι η συνολική αγοραία αξία των μετοχών μιας εισηγμένης εταιρείας και χρησιμοποιείται συνήθως για να προσδιοριστεί η αξία μιας εταιρείας.
Ιστορικό κεφαλαιοποίησης αγοράς της Biostar Pharmaceuticals, Inc. από 2008 έως 2026
BSPM σε σύγκριση με τα 5 πιο δημοφιλή stocks
Η τιμή για BSPM Το περιουσιακό στοιχείο B Η κεφαλαιοποίηση αγοράς του B Αποτελέσματα
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$2,055,299 $264.00
$5.426T +2,055,298,683,037.50%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,680,645 $264.00
$4.437T +1,680,645,217,339.39%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,571,025 $264.00
$4.148T +1,571,024,750,840.53%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,387,818 $264.00
$3.664T +1,387,818,418,650.00%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,094,413 $264.00
$2.889T +1,094,412,685,127.27%